Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-24 | Gregory B. Brown, M.D. was appointed to the Caladrius Board in October 2016 and was elected Chairman by the Caladrius Board on February 16, 2017. In 2007, Dr. Brown co-founded and became Vice Chairman of HealthCare Royalty Partners... He has been involved in sourcing, performing due diligence on and closing more than $1 billion of royalty financings. |
| 2019-04-30 | Gregory B. Brown, M.D. was appointed to the Caladrius Board in October 2016 and was elected Chairman by the Caladrius Board on February 16, 2017. |
| 2020-04-29 | Gregory B. Brown, M.D., was appointed to the Caladrius Board in October 2016 and was elected Chairman by the Caladrius Board on February 16, 2017. |
| 2021-04-28 | Dr. Brown is currently Chief Executive Officer of Memgen, Inc., a development-stage biotechnology company. |
| 2023-05-01 | Dr. Brown is currently Chief Executive Officer of Memgen, Inc., a development-stage biotechnology company. |
| 2024-04-29 | Gregory B. Brown, M.D. was appointed to our board of directors in October 2016 and was elected Chairman by our board of directors on February 16, 2017. Dr. Brown is currently Chief Executive Officer of Memgen, Inc., a development-stage biotechnology company. |
Data sourced from SEC filings. Last updated: 2025-07-01